Tech Company Financing Transactions

10X Genomics Funding Round

Meritech Capital Partners, Fidelity Management & Research Company and Paladin Capital Group participated in a $50 million Series D funding round for 10X Genomics. The round closed on 4/27/2018.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

7068 Koll Center Pkwy. 401
Pleasanton, CA 94566
USA

Phone

(925) 401-7300

Website

www.10xgenomics.com

Email Address

[email protected]

Overview

A transformative upgrade to short-read sequencers that fits easily into existing lab infrastructure. DNA or Cellular Input For DNA applications, start with only 1 ng of DNA. For single-cell applications, start with thousands of cells.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Serge Saxonov

        

Chief Financial Officer

Justin McAnear

        

Chief Scientific Officer

Ben Hindson

        

Vice President

Alexander Wong

        

VP - Finance

Jamie Osborn

        

VP - General Counsel

Eric Whitaker

        

VP - Human Resources

Jean Philibert

        

VP - Operations

Jonathan Schimmel

        

VP - Operations

Paul Wyatt

        

VP - Product Management

Michael Schnall-Levin

        

VP - Sales

Sam Ropp

        

Browse more venture capital transactions:

Prev: 4/27/2018: IFTTT venture capital transaction
Next: 4/27/2018: NanoMech venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to report on all VC transactions involving tech companies. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary